MNBTD
GBT

Moody National Bank Trust Division’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Moody National Bank Trust Division’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$5K – 1059
2019
Q1 		$5K Hold
100
– – ﹤0.01% 988
2018
Q4 		$4K Buy
+100
New +$3.75K ﹤0.01% 1029

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Moody National Bank Trust Division's GBT Position: Q2 2019 in Review

Moody National Bank Trust Division sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2019, closing a stake of 100 shares — an estimated $5K sold.

Moody National Bank Trust Division first reported a position in GBT in Q4 2018 and held it in 2 quarters. The position peaked at $5K in Q1 2019. 223 funds tracked by Wall St. Rank hold GBT as of Q2 2019.

  • Moody National Bank Trust Division reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 100 Global Blood Therapeutics, Inc. shares in Q2 2019, an estimated $5K.
  • Moody National Bank Trust Division first reported a position in Global Blood Therapeutics, Inc. in Q4 2018 and held it in 2 quarters.
  • Moody National Bank Trust Division's Global Blood Therapeutics, Inc. position peaked at $5K in Q1 2019.
  • 223 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2019.

Based on Moody National Bank Trust Division's 13F filing for Q2 2019, filed 22 Jul 2019.